Charles A. Scanga
- Infectious Diseases top 0.5%
- Tuberculosis Research and Epidemiology 38
- Immunology top 1%
- Immune Response and Inflammation 13
- Immune Cell Function and Interaction 11
- Immune responses and vaccinations 8
- Epidemiology top 1%
- Mycobacterium research and diagnosis 20
- Pneumocystis jirovecii pneumonia detection and treatment 5
- Parasitology top 1%
- Virology top 2%
- HIV Research and Treatment 11
-
- Infectious Diseases and Tuberculosis 7
Charles A. Scanga
62 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 110
- Infectious Diseases 2.5k
- Immunology 2.1k
- Epidemiology 2.1k
- Parasitology 386
- Virology 243
Countries citing papers authored by Charles A. Scanga
This map shows the geographic impact of Charles A. Scanga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles A. Scanga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles A. Scanga more than expected).
Fields of papers citing papers by Charles A. Scanga
This network shows the impact of papers produced by Charles A. Scanga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles A. Scanga. The network helps show where Charles A. Scanga may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles A. Scanga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 4 | |
| 5 | 2021 | 12 | |
| 6 | 2021 | 10 | |
| 7 | 2020 | 23 | |
| 8 | 2019 | 42 | |
| 9 | 2018 | 17 | |
| 10 | 2017 | 38 | |
| 11 | 2016 | 9 | |
| 12 | 2014 | 94 | |
| 13 | 2010 | 2 | |
| 14 | 2005 | 476 | |
| 15 | 2004 | 81 | |
| 16 | 2003 | 163 | |
| 17 | 2003 | 50 | |
| 18 | 2002 | 389 | |
| 19 | 2000 | 126 | |
| 20 | Serologic evidence of infection with lymphocytic choriomeningitis virus, the agent of callitrichid hepatitis, in primates in zoos, primate research centers, and a natural reserve | 1993 | 3 |
About Charles A. Scanga
Charles A. Scanga is a scholar working on Infectious Diseases, Virology and Immunology, having authored 66 papers that have together received 4.4k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (38 papers), Mycobacterium research and diagnosis (20 papers), Immune Response and Inflammation (13 papers), HIV Research and Treatment (11 papers), Immune Cell Function and Interaction (11 papers), Immune responses and vaccinations (8 papers), Infectious Diseases and Tuberculosis (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). The work is most often cited by research in Infectious Diseases (2.5k citations), Immunology (2.1k citations) and Epidemiology (2.1k citations). Charles A. Scanga has collaborated with scholars based in United States, Brazil and China. Frequent co-authors include JoAnne L. Flynn, Alan Sher, André Báfica, Kathryn E. Tanaka, Carl G. Feng, Allen W. Cheever, Vellore P. Mohan, John Chan, Keming Yu and Júlio Aliberti. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.